Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma

Cancer Research

Volumn 74, Issue 4, 2014, Pages 1056-1066

  Nomura, Motonari ^a,b   Ueno, Ayumi ^a   Saga, Kotaro ^a   Fukuzawa, Masahiro ^b   Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS; CALCIUM; CHICK EMBRYO; CYTOSOL; HAPLORHINI; HUMANS; MICE; MICE, SCID; NECROSIS; NEUROBLASTOMA; RESPIROVIRUS; TUMOR CELLS, CULTURED;

EID: 84894279534     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1283     Document Type: Article

References (38)

1. Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007;7:31-40.
2. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-14.
3. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000;1: 489-95.
4. Peter ME. Programmed cell death: apoptosis meets necrosis. Nature 2011;471:310-2.
5. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008;135:1161-3.
6. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137:1112-23.
7. Declercq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009;138:229-32.
8. Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 2011;44:9-16.
9. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010;3:re4.
10. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*-Stat mortality database: total U.S. (1969-2006), National Cancer Institute, DCCPS, Surveillance Research Program [database on the Internet]. Atlanta, GA: Centers for Disease Control and Prevention. Available from: www.cdc.gov/nchs. Accessed August 3, 2012.
11. Haase GM, Perez C, Atkinson JB. Current aspects of biology, risk assessment, and treatment of neuroblastoma Semin Surg Oncol 1999;16:91-104.
12. 2 release. Neoplasia 2003; 5:457-66.
13. Nomura M, Shimbo T, Miyamoto Y, Fukuzawa M, Kaneda Y. 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma. Cancer Sci 2013;104: 238-44.
14. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002;6:219-26.
15. Saga K, Tamai K, Yamazaki T, Kaneda Y. Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-g production. Clin Cancer Res 2013;19:668-79.
16. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005;1: 112-9.
17. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins Nat Chem Biol 2008;4:313-21.
18. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011;471:363-7.
19. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, etal. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011;471:368-72.
20. Tabata K, Hamano A, Akihisa T, Suzuki T. Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-indepen-dent cell death of neuroblastoma cells. Cancer Sci 2012;103: 2153-8.
21. Delavallee L, Cabon L, Galan-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2011;63:221-32.
22. Kawaguchi Y, Miyamoto Y, Inoue T, Kaneda Y. Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. Int J Cancer 2009;124:2478-87.
23. Tanaka M, Shimbo T, Kikuchi Y, Matsuda M, Kaneda Y. Sterile alpha motif containing domain 9 (SAMD9) is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon. Int J Cancer 2010;126: 1982-91.
24. Kaneda Y. Update on non-viral delivery methods for cancer therapy; possibilities of DDS with anti-cancer activities beyond delivery as a new therapeutic tool. Expert Opin Drug Deliv 2010; 9:1079-93.
25. Kurooka M, Kaneda Y. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res 2007;67:227-36.
26. Fujihara A, Kurooka M, Miki T, Kaneda Y. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunol Immunother 2008;57:73-84.
27. Matsushima-Miyagi T, Hatano K, Nomura M, Li-Wen L, Nishikawa T, Saga K, et al. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. Clin Cancer Res 2012;18:6271-83.
28. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993; 221:18-41.
29. Kaneda Y. Applications of hemagglutinating virus of Japan in therapeutic delivery systems. Expert Opin Drug Deliv 2008;5: 221-33.
30. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20.
31. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010;140:397-408.
32. 2+ before cell fusion. Biochem J 1982;206: 671-4.
33. Kunzelmann K, Konig J, Sun J, Markovich D, King NJ, Karupiah G, etal. Acute effects of parainfluenza virus on epithelial electrolyte transport. J Biol Chem 2004;279:48760-6.
34. Falvo JV, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, Tsai EY, et al. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 2000;20: 2239-47.
35. Zhu J, Coyne CB, Sarkar SN. PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and b-catenin. EMBO J 2011;30:4838-49.
36. Bayer KU, DeKoninck P, Leonard AS, Hell JW, Schulman H. Interaction with the NMDA receptor locks CaMK II in an active conformation. Nature 2001;411:801-5.
37. Meyer T, Hanson PI, Stryer L, Schulman H. Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 1992;256: 1199-202.
38. Narayan N, Lee IH, Borenstein R, Sun J, Wong R, Tong G, et al. The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 2012;492:199-204.